✦ LIBER ✦

Alendronate in the treatment of low bone mass in steroid-treated boys with Duchenne’s muscular dystrophy

✍ Scribed by Gillian A. Hawker; Rowena Ridout; Vivien A. Harris; Cheryl C. Chase; Lynda J. Fielding; W. Douglas Biggar

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of bisphosphonates on bone mass

✍ R.R. Scott; A. Huynh; N. Alos; Y. Brousseau; G. Chabot 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Targeting parents for the treatment of p

✍ Arikian, A.; Boutelle, K.; Peterson, C. B.; Dalton, J.; Day, J. W.; Crow, S. J. 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 126 KB

Influence of a two-year steroid treatmen

✍ Vuillerot, Carole; Braillon, Pierre; Fontaine-Carbonnel, Stephanie; Rippert, Pas 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 340 KB

Influence of a 2-year steroid treatment

✍ Vuillerot, C.; Braillon, P.; Fontaine-Carbonnel, S.; Rippert, P.; Andre, E.; Iwa 📂 Article 📅 2014 🏛 Elsevier 🌐 French ⚖ 268 KB

S.P.2 Disease progression as measured by

✍ Goemans, N.M.; van den Hauwe, M.; van Impe, A.; Mercier, T.; Wilson, R.; Buyse, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Intravenous zoledronic acid 5 mg in the

✍ Michael McClung; Robert Recker; Paul Miller; Darrell Fiske; Jerome Minkoff; Audr 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 189 KB